Potentially malignant and malignant lesions of the lip. Role of silver staining nucleolar organizer regions, proliferating cell nuclear antigen, p53, and c-myc in differentiation and prognosis

被引:0
|
作者
de Rosa, I
Staibano, S
Lo Muzio, L
Delfino, M
Lucariello, A
Coppola, A
De Rosa, G
Scully, C
机构
[1] Univ Naples Federico II, Dept Biomorphol & Funct Sci, Pathol Sect, Naples, Italy
[2] Univ Naples Federico II, Inst Dent Sci, Naples, Italy
[3] Univ Naples Federico II, Dermatol Clin, Naples, Italy
[4] Univ Naples Federico II, Div Med 3, Naples, Italy
[5] Univ London, Eastman Dent Inst Oral Hlth Care Sci, London, England
关键词
AgNOR; carcinogenesis; c-myc; lip; p53; PCNA;
D O I
暂无
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
The cellular changes leading to carcinoma of the lip are still not completely understood. This study was carried out on 44 malignant and potentially malignant lesions of the lower lip [30 squamous cell carcinomas (SCC), 7 actinic cheilitis, 3 leukoplakias, and 4 nodal metastases from lower lip SCC]. Silver-stained nucleolar organizer regions (AgNORs) and the immunohistochemical expression of proliferating cell nuclear antigen (PCNA), p53, and c-myc were evaluated on formalin-fixed, paraffin-embedded sections. The results indicate that the size and numbers of AgNORs and the percentage of PCNA-positive cells are sensitive parameters for discriminating between potentially malignant lesions and SCC, and for the prognostic sub-typing of lower lip SCC. Furthermore, while p53 positivity was found more frequently in high-grade carcinomas, p53-positive cellular clones were also found in some potentially malignant lesions, a finding probably related to ultraviolet-related cellular damage. These p53-positive lesions could be considered at higher risk of progression to malignancy than the p53-negative ones, although there is no evidence for this as yet, c-myc positivity was found only in some high-grade carcinomas and metastases, and appeared correlated with the later phases of lip carcinogenesis. The combined evaluation of the proliferation status, together with the changes in p53 and c-myc oncoproteins, might constitute useful markers for the prognostic evaluation of potentially malignant, as well as malignant, lesions of the lip.
引用
收藏
页码:252 / 258
页数:7
相关论文
共 32 条
  • [1] p53 alteration, proliferating cell nuclear antigen, and nucleolar organizer regions in thymic epithelial tumors
    Oyama, T
    Osaki, T
    Mitsudomi, T
    Ogawa, R
    Nakanishi, R
    Sugio, K
    Yasumoto, K
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 1998, 1 (05) : 823 - 826
  • [2] THYMIC EPITHELIAL TUMORS - EVALUATION OF MALIGNANT GRADE BY QUANTIFICATION OF PROLIFERATING CELL NUCLEAR ANTIGEN AND NUCLEOLAR ORGANIZER REGIONS
    TATEYAMA, H
    MIZUNO, T
    TADA, T
    EIMOTO, T
    HASHIMOTO, T
    MASAOKA, A
    VIRCHOWS ARCHIV A-PATHOLOGICAL ANATOMY AND HISTOPATHOLOGY, 1993, 422 (04) : 265 - 269
  • [3] PROLIFERATING CELL NUCLEAR ANTIGEN, KI-67, C-MYC P62 ONCOPROTEIN, AND NUCLEOLAR ORGANIZER REGIONS IN HODGKINS-DISEASE
    TSENGA, A
    KORKOLOPOULOU, P
    PATSOURIS, E
    PANGALIS, GA
    OATES, J
    SKOPELITOU, A
    ELEMENOGLOU, J
    KITTAS, C
    APPLIED IMMUNOHISTOCHEMISTRY, 1994, 2 (03): : 191 - 196
  • [4] Expression of topoisomerase IIα, Ki-67, proliferating cell nuclear antigen, p53, and argyrophilic nucleolar organizer regions in vulvar squamous lesions
    Brustmann, H
    Naudé, S
    GYNECOLOGIC ONCOLOGY, 2002, 86 (02) : 192 - 199
  • [5] Evaluations of p53 immunoreactivity, nucleolar organizer regions, and proliferating cell nuclear antigen in non-small cell lung carcinoma
    Oyama, T
    Osaki, T
    Nose, N
    Ichiki, Y
    Inoue, M
    Imoto, H
    Yoshimatsu, T
    Kodate, M
    Uramoto, H
    Mizoue, T
    Yano, K
    Yasumoto, K
    ANTICANCER RESEARCH, 2000, 20 (1B) : 505 - 510
  • [6] Expressions of proliferation markers (Ki-67, proliferating cell nuclear antigen, and silver-staining nucleolar organizer regions) and of p53 tumor protein in gestational trophoblastic disease
    Kale, A
    Söylemez, F
    Ensari, A
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2001, 184 (04) : 567 - 574
  • [7] COMPARATIVE IMMUNOHISTOCHEMICAL STUDIES OF P53 AND PROLIFERATING CELL NUCLEAR ANTIGEN EXPRESSION AND ARGYROPHILIC NUCLEOLAR ORGANIZER REGIONS IN PANCREATIC DUCT CELL CARCINOMAS
    SUZUKI, T
    TAKANO, Y
    JAPANESE JOURNAL OF CANCER RESEARCH, 1993, 84 (10): : 1072 - 1077
  • [8] COMPARISON OF SILVER-STAINING NUCLEOLAR ORGANIZER REGION (AGNOR) COUNTS AND PROLIFERATING CELL NUCLEAR ANTIGEN (PCNA) EXPRESSION IN REACTIVE MESOTHELIAL HYPERPLASIA AND MALIGNANT MESOTHELIOMA
    BETHWAITE, PB
    DELAHUNT, B
    HOLLOWAY, LJ
    THORNTON, A
    PATHOLOGY, 1995, 27 (01) : 1 - 4
  • [9] IMMUNOSTAINING FOR P53 AND PROLIFERATING CELL NUCLEAR ANTIGEN (PCNA) IN BENIGN AND MALIGNANT HUMAN ENDOMETRIUM
    YU, CCW
    BRITO, MJ
    WILKINSON, NB
    BUCKLEY, CH
    FOX, H
    LEVISON, DA
    JOURNAL OF PATHOLOGY, 1992, 168 : A133 - A133
  • [10] P53, C-MYC P62 AND PROLIFERATING CELL NUCLEAR ANTIGEN (PCNA) EXPRESSION IN NON-HODGKINS-LYMPHOMAS
    KORKOLOPOULOU, P
    OATES, J
    KITTAS, C
    CROCKER, J
    JOURNAL OF CLINICAL PATHOLOGY, 1994, 47 (01) : 9 - 14